Frankfurt
02.06.26 | 08:14
8,550 Euro
-0,12 % -0,010
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,530 | 8,930 | 02.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.05. | Nexstim Oyj: Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option Holders | 197 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 13 May 2026 at 09:05 AM (EEST)
Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain... ► Artikel lesen | |
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| 28.04. | Nexstim Oyj: Nexstim Plc Business Update Q1 2026 | 304 | GlobeNewswire (Europe) | Press release, Helsinki, 28 April 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q1 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 17.04. | Nexstim Oyj: Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029 | 132 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 17 April 2026 at 9 AM (EEST)
Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029
The Board of Directors of Nexstim... ► Artikel lesen | |
| 30.03. | Nexstim Oyj: Nexstim Plc: Resolutions of the Annual General Meeting | 144 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 March 2026 at 1:30 PM (EEST)
Nexstim Plc: Resolutions of the Annual General Meeting
Nexstim Plc ("Nexstim" or "Company") announces the following resolutions of the... ► Artikel lesen | |
| 23.03. | Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) | 305 | GlobeNewswire (Europe) | Press release, Helsinki, 23 March 2026 at 10:30 AM (EET)
Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
Nexstim Plc ("Nexstim" or "Company") announces... ► Artikel lesen | |
| 26.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2025 | 520 | GlobeNewswire (Europe) | Company announcement, Helsinki 26 February 2026 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2025
NEXSTIM ACCELERATED GROWTH AND ACHIEVED A PROFITABLE RESULT
January-December 2025
The... ► Artikel lesen | |
| 19.02. | Nexstim Oyj: Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation | 208 | GlobeNewswire (Europe) | Press release, Helsinki, 19 February 2026 at 9 AM (EET)
Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
Nexstim Plc ("Nexstim" or "Company") has... ► Artikel lesen | |
| 16.02. | Nexstim Oyj: Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE | 424 | GlobeNewswire (Europe) | Press release, Helsinki, 16 February 2026 at 11:30 AM (EET)
Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE
Nexstim Plc ("Nexstim" or "Company") has received import clearance for... ► Artikel lesen | |
| 02.02. | Nexstim Oyj: Nexstim Receives System Order from Distributor in India | 273 | GlobeNewswire (Europe) | Press release, Helsinki, 2 February 2026 at 9 AM (EET)
Nexstim Receives System Order from Distributor in India
Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through... ► Artikel lesen | |
| 30.12.25 | Nexstim Receives U.S. Order For Two NBS 6 Therapy Systems | 5 | RTTNews | ||
| 30.12.25 | Nexstim Oyj: US Customer Orders Two Nexstim NBS 6 Therapy Systems | 414 | GlobeNewswire (Europe) | Press release, Helsinki, 30 December 2025 at 9 AM (EET)
US Customer Orders Two Nexstim NBS 6 Therapy Systems
Nexstim Plc ("Nexstim" or "Company") has received an order for two NBS 6 therapy systems... ► Artikel lesen | |
| 23.12.25 | Nexstim Oyj: Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. | 230 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 23 December 2025 at 9 AM (EET)
Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc.
Nexstim Plc ("Nexstim"... ► Artikel lesen | |
| 16.09.25 | Nexstim Oyj: Nexstim Receives NBS 5+ System Order from Therapy Customer in United States | 217 | GlobeNewswire (Europe) | Press release, Helsinki, 16 September 2025 at 9 AM (EEST)
Nexstim Receives NBS 5+ System Order from Therapy Customer in United States
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| 15.08.25 | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2025 (unaudited) | 260 | GlobeNewswire (Europe) | NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2025 (UNAUDITED)
Company announcement, Helsinki, August 15, 2025 at 9 am (EEST)
NEXSTIM ACCELERATED GROWTH AND IMPROVED PROFITABILITY IN THE FIRST HALF... ► Artikel lesen | |
| 08.08.25 | Nexstim Oyj: Nexstim Receives NBS System 5 Order from India | 411 | GlobeNewswire (Europe) | Press release, Helsinki, 8 August 2025 at 10 AM (EEST)
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an Indian distributor.
The end customer is a hospital... ► Artikel lesen | |
| 30.06.25 | Nexstim Oyj: Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration | 202 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 June 2025 at 9 AM (EEST)
Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration
Nexstim Plc (NXTMH:HEX)... ► Artikel lesen | |
| 23.06.25 | Nexstim Oyj: Nexstim Receives NBS System 5 Order from a University Hospital in Germany | 295 | GlobeNewswire (Europe) | Press release, Helsinki, 23 June 2025 at 9 AM (EEST)
Nexstim Receives NBS System 5 Order from a University Hospital in Germany
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| VERU | 2,360 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | --Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter calendar year 2027- --Company to host conference call and... ► Artikel lesen | |
| NYXOAH | 2,355 | -1,26 % | Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum | Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum Mont-Saint-Guibert, Belgium - May 20, 2026, 10:05 pm CET / 4:05 pm ET - Nyxoah... ► Artikel lesen | |
| OPTOMED | 1,474 | -2,64 % | Optomed Oyj: Decisions of the Annual General Meeting | Optomed Plc Stock Exchange Release 8 May 2026 at 2.30 p.m., Helsinki
Decisions of the Annual General Meeting The Annual General Meeting held on 8 May 2026 adopted the financial statements for the... ► Artikel lesen | |
| MODULIGHT | 1,220 | 0,00 % | Modulight Oyj: Resolutions of Modulight Corporation's Annual General Meeting and Inaugural Meeting of the Board of Directors on 4 May 2026 | Modulight Corporation | Company Release | May 04, 2026 at 15:55:00 EEST
The Annual General Meeting of Modulight Corporation was held on 4 May 2026 at 1 p.m. (Finnish time) at Kampusareena Auditorium... ► Artikel lesen | |
| FRESENIUS | 36,450 | +2,82 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 35,690 | -1,95 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,34 | -1,07 % | Morgan Stanley raises BrightSpring Health price target on valuation | ||
| ALIGNMENT HEALTHCARE | 13,640 | 0,00 % | Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report | ||
| SIEMENS HEALTHINEERS | 34,040 | -0,64 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 4,310 | 0,00 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,760 | 0,00 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 25,115 | -4,14 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| GENEDX | 53,07 | 0,00 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| BILLIONTOONE | 94,01 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen |
NEXSTIM OYJ gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,010 (-0,12 %) liegt der Kurs bei 8,550 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSTIM OYJ finden Sie auf Wallstreet Online.